Vaccinex, Inc. announced that it has entered into definitive agreements with certain institutional investors for the purchase and sale of warrants to purchase up to an aggregate of 193,000 shares of common stock in a concurrent private placement at a combined purchase price of $7.77 per share for the gross proceeds of $1,499,610 on March 27, 2024. The warrants will have an exercise price of $7.64 per share, will be immediately exercisable upon issuance and will expire 5 years from the initial exercise date. The closing of the transactions is expected to occur on or about March 28, 2024, subject to the satisfaction of customary closing conditions.

The private placement of the warrants and the separate private placement of common stock together with warrants are being made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D thereunder.